Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
24 Results for "
face
" in MedChemExpress (MCE) Product Catalog:
Products (24)
24 Results for "face" in MCE Product Catalog:
30
30 Publications Verification
Synonyms: α-Hypophamine; Oxytocic hormone
30
30 Publications Verification
Synonyms: α-Hypophamine acetate; Oxytocic hormone acetate
10
10 Cited Publications
Apcin, a ligand of Cdc20, is a potent and competitive anaphase-promoting complex/cyclosome (APC/C(Cdc20)) E3 ligase activity inhibitor. Apcin competitively inhibits APC/C-dependent ubiquitylation by binding to Cdc20 and preventing substrate recognition. Apcin occupes the D-box-binding pocket on the side face of the WD40-domain and can prolong mitosis .
Cat. No.: HY-P5726
CAS No.: 302343-01-7
Target:
Cat. No.: HY-P0065
CAS No.: 868844-74-0
Target:
Research Areas:
Acetyl octapeptide-1 is a competitive inhibitor of SNAP-25. Acetyl octapeptide-1 affects muscle contraction, thereby making the face (especially the forehead and periocular area) appear smoother and wrinkle-free. Acetyl octapeptide-1 can be used in research on muscle contraction and skincare products .
Cat. No.: HY-W010507
CAS No.: 3976-69-0
Synonyms: Methyl (R)-(-)-3-hydroxybutyrate
Cat. No.: HY-W127452
CAS No.: 3398-33-2
Cat. No.: HY-158104
Cat. No.: HY-W739372
CAS No.: 25704-18-1
Target:
Research Areas:
Poly (sodium 4-styrenesulfonate) is an anionic cation-exchange polyelectrolyte and metal ion binding/retention agent. It selectively retains Cr III and Fe II under pH 1 conditions, and its retention effect on all tested metal ions is enhanced under higher pH conditions. Poly (sodium 4-styrenesulfonate) inhibits nanosheet aggregation through edge-face interactions between aromatic rings and the graphite surface, thereby stabilizing the dispersion of reduced graphene oxide nanosheets. When incorporated into the mixed Nafion coating of bismuth film electrodes, Poly (sodium 4-styrenesulfonate) improves the reproducibility, stability, sensitivity, and anti-fouling capability for trace metal detection .
Cat. No.: HY-RS04736
Target:
Research Areas:
FANCE Human Pre-designed siRNA Set A contains three designed siRNAs for FANCE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS04326
Target:
Research Areas:
ELOVL6 Human Pre-designed siRNA Set A contains three designed siRNAs for ELOVL6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-130004
CAS No.: 2909443-13-4
Target:
Research Areas:
MsbA-IN-6 is a potent inhibitor of MsbA. MsbA-IN-6 is an antibiotic. Gram-negative ATP-binding cassette (ABC) transporter MsbA, an essential inner membrane protein, transports lipopolysaccharide from the inner leaflet to the periplasmic face of the inner membrane. MsbA-IN-6 kills Escherichia coli through inhibition of its ATPase and transport activity, with no loss of activity against clinical multidrug-resistant strains .
Cat. No.: HY-167690
CAS No.: 1034474-19-5
Target:
Research Areas:
MK-6186 is a novel non-nucleoside reverse transcriptase inhibitor with sub-nanomolar activity against wild-type viruses and the two most common NNRTI-resistant RT mutants (K103N and Y181C). MK-6186 exhibits excellent antiviral activity against K103N and Y181C mutant viruses. When MK-6186 targets 12 common NNRTI-associated mutant viruses, only two relatively rare mutants (Y188L and V106I/Y188L) show high resistance, with FC values exceeding 100, while the FC values of the remaining viruses are all below 10. In addition, when MK-6186 faces 96 clinical virus isolates carrying NNRTI-resistant mutations, most (70%) viruses show more than 10-fold resistance to efavirenz (EFV), while only 29% of mutant viruses show more than 10-fold resistance to MK-6186 .
Cat. No.: HY-P810996
Synonyms: face, LCE, ELOVL6, Very long chain fatty acid elongase 6, 3-keto acyl-CoA synthase ELOVL6, ELOVL fatty acid elongase 6, Elongation of very long chain fatty acids protein 6, Fatty acid elongase 2, Fatty acyl-CoA elongase, Long-chain fatty-acyl elongase, Very long chain 3-ketoacyl-CoA synthase 6, Very long chain 3-oxoacyl-CoA synthase 6, ELOVL FA elongase 6, hELO2
Cat. No.: HY-17571BS
Synonyms: α-Hypophamine-d10 TFA; Oxytocic hormone-d10 TFA
Cat. No.: HY-17571S
Synonyms: α-Hypophamine-13C6,15N TFA; Oxytocic hormone-13C6,15N TFA
Research Areas:
Oxytocin- 13C6, 15N (α-Hypophamine- 13C6, 15N) TFA is the 13C- and 15N-labeled Oxytocin TFA. Oxytocin (α-Hypophamine; Oxytocic hormone) is a pleiotropic, hypothalamic peptide known for facilitating parturition, lactation, and prosocial behaviors. Oxytocin can function as a stress-coping molecule with anti-inflammatory, antioxidant, and protective effects especially in the face of adversity or trauma.
Cat. No.: HY-110287R
CAS No.: 300815-04-7
Target:
Research Areas:
Apcin (Standard) is the analytical standard of Apcin (HY-110287). This product is intended for research and analytical applications. Apcin, a ligand of Cdc20, is a potent and competitive anaphase-promoting complex/cyclosome (APC/C(Cdc20)) E3 ligase activity inhibitor. Apcin competitively inhibits APC/C-dependent ubiquitylation by binding to Cdc20 and preventing substrate recognition. Apcin occupes the D-box-binding pocket on the side face of the WD40-domain and can prolong mitosis .
Cat. No.: HY-184616
Nanomaterials with sizes ranging from 1 to 100 nm are generally referred to as nanocrystals. The preparation of platinum nanocrystals with controllable morphology was first reported in 1996. Pt, Ag, Au, Rh, and other nanocrystals have been synthesized using various methods. Platinum has a face-centered cubic (fcc) structure, but unlike Ag, Au, and Pd, it rarely forms twins; most platinum nanocrystals are single-crystal structures. XFJ116 platinum nanoparticles were prepared via a chemical reduction method, exhibiting uniform size and good dispersibility, and can also provide platinum nanoparticles with amino and carboxyl terminator modifications.
Cat. No.: HY-187364
CAS No.: 3050594-88-9
Target:
Research Areas:
TRPV4 antagonist-7 is a potent and selective TRPV4 antagonist with an IC50 of 0.2 nM against human targets. TRPV4 antagonist-7 binds to the voltage-sensor-like domain cavity of TRPV4 and inhibits channel activity through the formation of salt bridges, hydrogen bonds, and edge-to-face π-stacking interactions. TRPV4 antagonist-7 induces phospholipid accumulation in HepG2 C3A cells in vitro with an IC50 of 3.8 μM, and exhibits moderate inhibitory effects on CYP2D6 with an IC50 of 5.1 μM. TRPV4 antagonist-7 dose-dependently inhibits GSK1016790A (HY-19608)-induced bronchoconstriction in rats and cough in guinea pigs. TRPV4 antagonist-7 can be used in studies related to respiratory system diseases .
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
